Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation	Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia, core binding factor acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2024-08-22		NCT06316960

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Hospital of Soochow University	17

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Hospital of Fudan University	Shanghai	China	4
Children's Hospital Of Soochow University	Suzhou	China	3
First Affiliated Hospital Of University of Science and Technology of China	Hefei	China	2
Guangzhou Women and Children Medical Center	Guangzhou	China	3
Kaifeng Children's Hospital	Kaifeng	China	2
Qilu Hospital of Shandong University	Jinan	China	25
The First Affiliated Hospital of Guangxi Medical University	Nanning	China	11
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	125
The Second Hospital of Anhui Medical University	Hefei	China	5
Third Xiangya Hospital of Central South University	Changsha	China	2
Xiangya Hospital Central South University	Changsha	China	35
Xuzhou Children's Hospital	Xuzhou	China	3